Programmed Cell Death Ligand 1 Pathologist Training in the Time of COVID-19: Our Experience using a Digital Solution

The COVID-19 pandemic presented numerous challenges to the continuity of programmed cell death ligand 1 (PD-L1) assay training events conducted by our organization. Under typical conditions, these training events are face-to-face affairs, where participants are trained to assay algorithms on glass s...

Descripción completa

Detalles Bibliográficos
Autores principales: Hayden, Dorothy, Herndon, Joseph M., Campion, James C., Feng, Janine D., Lian, Fangru, Baumann, Jessica L., Roland, Bryan K., ElGabry, Ehab A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Technical Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652342/
https://www.ncbi.nlm.nih.gov/pubmed/34934522
http://dx.doi.org/10.4103/jpi.jpi_16_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652342/
https://www.ncbi.nlm.nih.gov/pubmed/34934522
http://dx.doi.org/10.4103/jpi.jpi_16_21

Ejemplares similares